1.47
price up icon3.52%   0.05
after-market After Hours: 1.52 0.05 +3.40%
loading
Galmed Pharmaceuticals Ltd stock is traded at $1.47, with a volume of 40,540. It is up +3.52% in the last 24 hours and down -2.65% over the past month. Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.
See More
Previous Close:
$1.42
Open:
$1.43
24h Volume:
40,540
Relative Volume:
0.21
Market Cap:
$8.05M
Revenue:
-
Net Income/Loss:
$-6.91M
P/E Ratio:
-0.4509
EPS:
-3.26
Net Cash Flow:
$-6.14M
1W Performance:
-8.70%
1M Performance:
-2.65%
6M Performance:
+11.36%
1Y Performance:
-61.82%
1-Day Range:
Value
$1.41
$1.47
1-Week Range:
Value
$1.41
$1.65
52-Week Range:
Value
$1.15
$4.81

Galmed Pharmaceuticals Ltd Stock (GLMD) Company Profile

Name
Name
Galmed Pharmaceuticals Ltd
Name
Phone
-
Name
Address
-
Name
Employee
6
Name
Twitter
@GalmedPharma
Name
Next Earnings Date
2025-08-19
Name
Latest SEC Filings
Name
GLMD's Discussions on Twitter

Compare GLMD with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
GLMD
Galmed Pharmaceuticals Ltd
1.47 7.78M 0 -6.91M -6.14M -3.26
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
407.37 104.55B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
464.95 60.36B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
557.73 59.84B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
799.56 49.07B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
327.03 35.16B 4.56B -176.77M 225.30M -1.7177

Galmed Pharmaceuticals Ltd Stock (GLMD) Upgrades & Downgrades

Date Action Analyst Rating Change
May-22-20 Downgrade B. Riley FBR Buy → Neutral
Feb-04-20 Initiated Craig Hallum Buy
Jan-30-20 Resumed Cantor Fitzgerald Overweight
Dec-02-19 Initiated Canaccord Genuity Buy
Dec-12-18 Initiated B. Riley FBR Buy
Aug-02-18 Reiterated Maxim Group Buy
Jul-13-18 Initiated Stifel Buy
Jul-12-18 Initiated Cantor Fitzgerald Overweight
Jun-12-18 Reiterated H.C. Wainwright Buy
Mar-15-18 Upgrade Maxim Group Hold → Buy
Feb-14-18 Downgrade Maxim Group Buy → Hold
Feb-12-18 Reiterated H.C. Wainwright Buy
Nov-15-17 Initiated ROTH Capital Buy
Aug-08-17 Reiterated H.C. Wainwright Buy
Jul-31-17 Reiterated Maxim Group Buy
Aug-01-16 Reiterated Maxim Group Buy
Jul-06-16 Resumed ROTH Capital Buy
Mar-28-16 Resumed H.C. Wainwright Buy
Jun-23-15 Initiated H.C. Wainwright Buy
May-06-15 Initiated Sun Trust Rbsn Humphrey Buy
View All

Galmed Pharmaceuticals Ltd Stock (GLMD) Latest News

pulisher
11:53 AM

What data driven models say about Galmed Pharmaceuticals Ltd.’s future2025 Historical Comparison & Reliable Intraday Trade Plans - newser.com

11:53 AM
pulisher
11:12 AM

How Galmed Pharmaceuticals Ltd. stock reacts to inflationary pressures2025 Key Highlights & Smart Money Movement Alerts - newser.com

11:12 AM
pulisher
11:12 AM

Is Galmed Pharmaceuticals Ltd. a candidate for recovery playTreasury Yields & Daily Market Momentum Tracking - newser.com

11:12 AM
pulisher
Oct 12, 2025

Can volume confirm reversal in Galmed Pharmaceuticals Ltd.Inflation Watch & Verified Technical Signals - newser.com

Oct 12, 2025
pulisher
Oct 10, 2025

Why Galmed Pharmaceuticals Ltd. stock remains on buy listsProfit Target & AI Powered Market Entry Strategies - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

What institutional flow reveals about Galmed Pharmaceuticals Ltd.2025 Price Targets & Community Consensus Picks - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Building trade automation scripts for Galmed Pharmaceuticals Ltd.July 2025 Patterns & Community Consensus Trade Alerts - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Is Galmed Pharmaceuticals Ltd. stock a top momentum playJuly 2025 Fed Impact & High Yield Stock Recommendations - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Will Galmed Pharmaceuticals Ltd. benefit from macro trendsJuly 2025 Short Interest & AI Enhanced Execution Alerts - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Galmed Pharmaceuticals Ltd.’s volatility index tracking explainedWeekly Trade Summary & Community Consensus Trade Signals - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

What drives Galmed Pharmaceuticals Ltd stock priceMid Cap Growth Trends & Investment Portfolio Recommendations - earlytimes.in

Oct 10, 2025
pulisher
Oct 10, 2025

Understanding Galmed Pharmaceuticals Ltd.’s price movementQuarterly Market Review & Comprehensive Market Scan Reports - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

How Galmed Pharmaceuticals Ltd. stock reacts to Fed rate cuts2025 Market Trends & Community Consensus Stock Picks - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Weiss Ratings Reiterates “Sell (E+)” Rating for Galmed Pharmaceuticals (NASDAQ:GLMD) - Defense World

Oct 09, 2025
pulisher
Oct 06, 2025

News impact scoring models applied to Galmed Pharmaceuticals Ltd.Weekly Trading Summary & Verified Momentum Stock Watchlist - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Will Galmed Pharmaceuticals Ltd. (GPH) stock outperform benchmarksShort Setup & Advanced Technical Analysis Signals - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

What the charts say about Galmed Pharmaceuticals Ltd. todayQuarterly Trade Review & Breakout Confirmation Trade Signals - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Galmed Pharmaceuticals Ltd. stock prediction for this weekJuly 2025 Breakouts & Reliable Trade Execution Plans - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Combining machine learning predictions for Galmed Pharmaceuticals Ltd.July 2025 Sector Moves & Stepwise Entry/Exit Trade Alerts - newser.com

Oct 05, 2025
pulisher
Oct 03, 2025

Published on: 2025-10-03 05:59:14 - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Can Galmed Pharmaceuticals Ltd. (GPH) stock withstand sector downturnsSwing Trade & Verified Chart Pattern Trade Signals - newser.com

Oct 03, 2025
pulisher
Sep 29, 2025

What drives Galmed Pharmaceuticals Ltd GPH stock priceRelative Strength Index (RSI) & High Yield Trading Growth - earlytimes.in

Sep 29, 2025

Galmed Pharmaceuticals Ltd Stock (GLMD) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$84.73
price up icon 1.11%
$22.93
price up icon 7.40%
$32.68
price up icon 2.73%
$102.30
price up icon 0.24%
$163.94
price up icon 0.99%
biotechnology ONC
$327.03
price up icon 2.16%
Cap:     |  Volume (24h):